Novo Holdings
International · active in EuropeMulti-stage fund
Seed Series-A Above Series A
Cheque range
£5M – £50M
Stages
Seed, Series A, Above Series A
Avg deals / year
8.5
Leads rounds
Yes
HQ
London
Fund type
Multi-stage fund
01 · Thesis & focus
Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise foundations.
02 · Recent publicly announced deals
Oxford spinout developing small-molecule drugs for endocrine and immune diseases.
Founders: Idlir L., Jonathan H.Copenhagen clinical-stage biotech developing oral therapies for retinal diseases
Stockholm biotech developing an oral drug for advanced heart failure
Founders: Lars L.03 · Similar firms
b2Venture AG£700k – £20M · Also Seed · Fintech
Inovia Capital£1M – £100M · Also Seed · Fintech
Oxford Science Enterprises£5M – £30M · Also Seed · Fintech
SwissCom Ventures£1M – £80M · Also Seed · Fintech
Benhamou Global Ventures£3M – £30M · Also Seed · Fintech
New Era Capital Partners£3M – £15M · Also Seed · Fintech
Suggest a correction — Novo Holdings
What looks wrong? We review every submission.
Prefer email? kudei@concept.vc
Refresh this card?
We re-check public sources and update stages, deals and fund news. Each card can be refreshed once a week.